Fig. 3From: Efficacy and safety of intravitreal aflibercept in ranibizumab-refractory patients with neovascular age-related macular degenerationDistribution of number of intravitreal aflibercept injections over the 12-month study. Per-protocol population. IVT-AFL = intravitreal afliberceptBack to article page
